Cost-Related Medication Nonadherence After the Inflation Reduction Act
This difference-in-differences analysis evaluates the association of the Inflation Reduction Act’s 2024 prescription drug provisions with cost-related medication nonadherence as well as health care–related financial strain. from JAMA Internal Medicine Online First https://ift.tt/4WKJmlU